OSu-PEG4-VC-PAB-MMAE

• UNSPSC Description:

  OSu-PEG4-VC-PAB-MMAE involves in GDP-FAmP4MMAE (Monomethylauristatin E) synthesis, which is for GDP label via site-specific conjugation[1].

• Target Antigen:

  Drug-Linker Conjugates for ADC

• Type:

  ADC Related

• Related Pathways:

  Antibody-drug Conjugate/ADC Related

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/osu-peg4-vc-pab-mmae.html

• Solubility:

  DMSO : 80 mg/mL (ultrasonic)

• Smiles:

  O[C@@H](C1=CC=CC=C1)[C@@H](C)NC([C@H](C)[C@H]([C@@]2([H])N(CCC2)C(C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C([C@H](C(C)C)NC([C@H](C(C)C)N(C)C(OCC3=CC=C(C=C3)NC([C@H](CCCNC(N)=O)NC([C@H](C(C)C)NC(CCOCCOCCOCCOCCC(ON4C(CCC4=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)OC)=O

• Molecular Weight:

  1496.78

• References & Citations:

  [1]Yang, et al. Preparation of site-specific antibody conjugates: World Intellectual Property Organization, WO2022037665[P]. 2022-02-24.

• Shipping Conditions:

  Blue Ice

• Clinical Information:

  No Development Reported

• CAS Number:

  2762518-86-3